A 44-yea r-old man presented with a I-year history of a right forehead mass. Over the previous 3 months, he had begun to feel increasing pressure and disco mfort around the mass. On physical examination, the palpable mass was present over the right brow (figure, A). Findings on the remainder of the head and neck exa mination were unremarkable. Co mputed tomography (CT) of the head identifi ed a well-circu mscribed lytic mass that involved the anterior table of the right frontal sinus (fig ure, B) . On CT, the lesion measured approximately II mm at its greatest dimension.
The anterior table of the right frontal sinus was resected, along with mucosal stripping for tumor removal (figure, C) . The supraorbital rim was reconstructed with a molded titanium mesh covered by hydroxyapatite cement (Mimix; Walter Lorenz Surgical; Jacksonville, Fla.). The cement was contoured to the defect. Histopathology was consistent with an intraosseous caverno us hemangioma.
Calvarial hemangiomas account for 20% of all hemangiomas but only 0.2% of all bone neoplasms.I Hemangiomas account for 1% of all bony neoplasms.I These neoplasms most commonly arise in the vertebral bodies, but when they do occur in the cranial bones, the frontal From the Osborne Head and Neck Institute. Los Angeles. 26 8 and parietal locations are most common. Hemangiomas are classified as capillary. cavern ous, or mixed, based on their histology. Microscopic examination will reveal hamartomatous proliferations of vascular tissue within endothelium-lined spaces.I The treatment of choice for calvarial hemangiomas is surgical resection with immediate reconstruction. Large lesions may require preoperative angiography with embolization. Reconstruction with autogenous bone (e.g., a calvarial bone graft) is the gold standard. Graft material can be harvested through the same incision.Alloplastic materials have also proven to be useful. They are expedie nt, and they can provide similar cos metic results without the risk of donor-site morbidity. In 2003, Eppley et al reported a series of 62 patients who had undergone craniop lasty with Mimix hydroxyapatite; 5% of these patients developed an infection that required removal of the implant material,"
